Keith Lee Spencer

This inventor holds 23 USPTO granted patents and 19 published patent applications, plus 6 CIPO patents and 14 EPO patents, primarily in AKT Protein Kinase Inhibitors. Top assignees: Array Biopharma Inc., Genentech, Inc., Merck + Co., Inc.. Active years: 2005-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith Lee Spencer. Retrieved from https://idiyas.com/inventor/keith-lee-spencer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 19)

% Patents Active = 65.2

CIPO Patents = 6 (Patent Applications = 1)

EPO Patents = 14 (Patent Applications = 11)

Average Co-Inventor Count = 8.7

ph-index = 9

Forward Citations = 205(Granted Patents)

Location History:

Hatfield, PA (US) (2005 - 2007)
Lyons, CO (US) (2009 - 2016)
Boulder, CO (US) (2014 - 2019)

Company Filing History:

where one patent can have more than one assignee

Years Active: 2005-2019

Loading Chart...

Areas of Expertise:

AKT Protein Kinase Inhibitors

Hydroxylated Cyclopentanes

Pyrimidyl Cyclopentanes

Substituted Piperazines

Dihydrofuro Pyrimidines

Tyrosine Kinase Inhibitors

Androgen Receptor Modulators

Methoxylated Pyrimidyl Compounds

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10329288 - Process for preparing a compound (2019-06-25),

2. 9790190 - Process for making hydroxylated cyclopentylpyrimidine compounds (2017-10-17),

3. 9676730 - Process for making hydroxylated cyclopentylpyrimidine compounds (2017-06-13),

4. 9416110 - Process for making hydroxylated cyclopentylpyrimidine compounds (2016-08-16),

5. 9409886 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2016-08-09),

6. 9359340 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors (2016-06-07),

7. 9309204 - Process for making hydroxylated cyclopentylpyrimidine compounds (2016-04-12),

8. 9303040 - Substituted piperazines as AKT inhibitors (2016-04-05),

9. 8853216 - Hydroxylated pyrimidyl cyclopentane as AKT protein kinase inhibitor (2014-10-07),

10. 8853199 - Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2014-10-07),

11. 8846683 - Pyrimidyl cyclopentanes as Akt protein kinase inhibitors (2014-09-30),

12. 8846681 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2014-09-30),

13. 8835434 - Hydroxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors (2014-09-16),

14. 8680114 - AKT protein kinase inhibitors (2014-03-25),

15. 8618097 - Pyrimidyl cyclopentanes as AKT protein kinase inhibitors (2013-12-31),

Title: The Innovative Mind of Keith Lee Spencer

Introduction: Keith Lee Spencer, a talented inventor hailing from Lyons, CO (US), is known for his groundbreaking contributions to the world of technology and innovation.

Latest Patents: Keith Lee Spencer's latest patents showcase his ingenuity in developing cutting-edge solutions for various industries, ranging from renewable energy to healthcare.

Career Highlights: With a career spanning over two decades, Keith Lee Spencer has established himself as a visionary inventor with a keen eye for identifying gaps in the market and creating innovative solutions to address them. His work has not only revolutionized existing technologies but has also paved the way for new advancements in the field.

Collaborations: Throughout his career, Keith Lee Spencer has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work seamlessly with multidisciplinary teams has been instrumental in the success of many projects.

Conclusion: In conclusion, Keith Lee Spencer's passion for innovation and his relentless drive to push the boundaries of what is possible have solidified his position as a prominent figure in the world of inventors. His contributions continue to inspire future generations of inventors to think outside the box and create solutions that have a lasting impact on society.

Profile summary based on public USPTO records.